Search research articles
Contact Us
Filters
Showing results (1-10 of 157) with videos related to
Page
of 16
Sort By:
Continuum (Minneapolis, Minn.)
|
October 12, 2022
Diagnosis and Treatment of Essential Tremor
Aparna Wagle Shukla
JAMA Neurology
|
June 13, 2017
Extended-Release Amantadine-A Smart Pill for Treatment of Levodopa-Induced Dyskinesia but Does the Evidence Justify the Cost?
Aparna Wagle Shukla
Tremor and Other Hyperkinetic Movements (New York, N.Y.)
|
August 11, 2022
Rationale and Evidence for Peripheral Nerve Stimulation for Treating Essential Tremor
Aparna Wagle Shukla
International Review of Neurobiology
|
June 24, 2022
Reduction of neuronal hyperexcitability with modulation of T-type calcium channel or SK channel in essential tremor
Aparna Wagle Shukla
JAMA Neurology
|
November 9, 2017
ADS 5102 (Amantadine) Extended Release for Levodopa-Induced Dyskinesia-Reply
Aparna Wagle Shukla
Toxicon : Official Journal of the International Society on Toxinology
|
August 13, 2023
Basis of movement control in dystonia and why botulinum toxin should influence it?
Aparna Wagle Shukla
Seminars in Neurology
|
May 7, 2026
Neurophysiological Basis of Tremor Disorders: Parkinson's Disease, Essential Tremor, Tremor in Dystonia, and Holmes Tremor
Aparna Wagle Shukla, Pattamon Panyakaew
Parkinsonism & Related Disorders
|
March 5, 2020
Reply to letter to the editor, "A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia."
Wei Hu, Aparna Wagle Shukla
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 18, 2019
Essential requisites for rest tremor assessment in Parkinson's disease
Zakia Jabarkheel, Aparna Wagle Shukla
Dystonia (Lausanne, Switzerland)
|
July 30, 2025
Clinical and physiological characteristics of tremor in a large cohort of focal and segmental dystonia
Zakia Jabarkheel, Aparna Wagle Shukla
Page
of 16
Search research articles
Search
Showing results (1-10 of 157) with videos related to
Sort By:
Page
of 16
Continuum (Minneapolis, Minn.)
|
October 12, 2022
Diagnosis and Treatment of Essential Tremor
Aparna Wagle Shukla
JAMA Neurology
|
June 13, 2017
Extended-Release Amantadine-A Smart Pill for Treatment of Levodopa-Induced Dyskinesia but Does the Evidence Justify the Cost?
Aparna Wagle Shukla
Tremor and Other Hyperkinetic Movements (New York, N.Y.)
|
August 11, 2022
Rationale and Evidence for Peripheral Nerve Stimulation for Treating Essential Tremor
Aparna Wagle Shukla
International Review of Neurobiology
|
June 24, 2022
Reduction of neuronal hyperexcitability with modulation of T-type calcium channel or SK channel in essential tremor
Aparna Wagle Shukla
JAMA Neurology
|
November 9, 2017
ADS 5102 (Amantadine) Extended Release for Levodopa-Induced Dyskinesia-Reply
Aparna Wagle Shukla
Toxicon : Official Journal of the International Society on Toxinology
|
August 13, 2023
Basis of movement control in dystonia and why botulinum toxin should influence it?
Aparna Wagle Shukla
Seminars in Neurology
|
May 7, 2026
Neurophysiological Basis of Tremor Disorders: Parkinson's Disease, Essential Tremor, Tremor in Dystonia, and Holmes Tremor
Aparna Wagle Shukla, Pattamon Panyakaew
Parkinsonism & Related Disorders
|
March 5, 2020
Reply to letter to the editor, "A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia."
Wei Hu, Aparna Wagle Shukla
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 18, 2019
Essential requisites for rest tremor assessment in Parkinson's disease
Zakia Jabarkheel, Aparna Wagle Shukla
Dystonia (Lausanne, Switzerland)
|
July 30, 2025
Clinical and physiological characteristics of tremor in a large cohort of focal and segmental dystonia
Zakia Jabarkheel, Aparna Wagle Shukla
Page
of 16